Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alessandro Ribechini

Squamous Cell Transformation and EGFR T790M Mutation as Acquired Resistance Mechanisms in a Patient With Lung Adenocarcinoma Treated With a Tyrosine Kinase Inhibitor: A Case Report

Oncology Letters

Cancer Research

Oncology

2017

English

Related publications

Mechanisms of Acquired Resistance to EGFR-tyrosine Kinase Inhibitor in Korean Patients With Lung Cancer

English

P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance

Journal of Thoracic Oncology

English

Case Report: Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Lung Adenocarcinoma Patient With Sarcomatoid Transformation

English

Newly Emergent Acquired EGFR Exon 18 G724S Mutation After Resistance of a T790M Specific EGFR Inhibitor Osimertinib in Non-Small-Cell Lung Cancer: A Case Report

OncoTargets and Therapy

Oncology

Pharmacology

2018

English

P3.17-14 a Case of a Patient Harboring an EGFR -T790m Mutation Positive in Squamous Cell Lung Cancer

Journal of Thoracic Oncology

English

The Association of Acquired T790M Mutation With Clinical Characteristics After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Cancer Research and Treatment

Cancer Research

Oncology

2018

English

Adenocarcinoma of the Lung With EGFR Gene Mutation and Subsequent Resistance Mechanisms Exploration: Case Report

OncoTargets and Therapy

Oncology

Pharmacology

2017

English

A Case of EGFR Mutant Lung Adenocarcinoma That Acquired Resistance to EGFR-tyrosine Kinase Inhibitors With MET Amplification and Epithelial-To-Mesenchymal Transition

OncoTargets and Therapy

Oncology

Pharmacology

2015

English

EGFR T790M Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Lung Adenocarcinoma Patients With Acquired Resistance to First Generation EGFR Tyrosine Kinase Inhibitors

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alessandro Ribechini

Squamous Cell Transformation and EGFR T790M Mutation as Acquired Resistance Mechanisms in a Patient With Lung Adenocarcinoma Treated With a Tyrosine Kinase Inhibitor: A Case Report

Related publications

Mechanisms of Acquired Resistance to EGFR-tyrosine Kinase Inhibitor in Korean Patients With Lung Cancer

P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance

Case Report: Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Lung Adenocarcinoma Patient With Sarcomatoid Transformation

Newly Emergent Acquired EGFR Exon 18 G724S Mutation After Resistance of a T790M Specific EGFR Inhibitor Osimertinib in Non-Small-Cell Lung Cancer: A Case Report

P3.17-14 a Case of a Patient Harboring an EGFR -T790m Mutation Positive in Squamous Cell Lung Cancer

The Association of Acquired T790M Mutation With Clinical Characteristics After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Adenocarcinoma of the Lung With EGFR Gene Mutation and Subsequent Resistance Mechanisms Exploration: Case Report

A Case of EGFR Mutant Lung Adenocarcinoma That Acquired Resistance to EGFR-tyrosine Kinase Inhibitors With MET Amplification and Epithelial-To-Mesenchymal Transition

EGFR T790M Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Lung Adenocarcinoma Patients With Acquired Resistance to First Generation EGFR Tyrosine Kinase Inhibitors